EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial

Abhijit Dutta, Arijit Manna, Shubhamoy Ghosh, Malay Mundle, Madhabananda Saha, Kumar Gourav, Sukhdeb Maiti, Bhargab Chattopadhyay

Complementary Medicine Research · 2024

DOI: 10.1159/000536395 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Complementary Medicine Research, 2024. Verfasst von Abhijit Dutta und 7 weiteren Autor:innen. Beteiligte Einrichtung: International Cooperation Section, Ministry of Ayush (Government of India), New Delhi, India. Hauptthemen laut MEDLINE: COVID-19, Homeopathy, Materia Medica, COVID-19 Drug Treatment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Homeopathic medicines have been used for decades in the prevention and treatment of infectious diseases. However, the preventive efficacy of specific homeopathic medicines in COVID-19 is not well characterized. This study aimed to evaluate the comparative efficacy of prespecified homeopathic medicines in preventing COVID-19.

Methods

A community-based, double-blind, randomized, placebo-controlled trial was conducted on 4,034 participants residing in Ward No. 27 of the Howrah Municipal Corporation in India. Participants were randomized to receive one of three prespecified homeopathic medicines [Influenzinum 30C, Arsenicum album 30C, Anas barbariae hepatis et cordis extractum 200K (Oscillococcinum®)], or placebo. The outcomes were the incidence of laboratory-confirmed and suspected cases of COVID-19 during a follow-up period of 1 month.

Results

During the follow-up period, a total of 13 new laboratory-confirmed COVID-19 cases were reported in the study population. Among these, 5 cases in Influenzinum group, 2 cases in Arsenicum album group, 1 case in Oscillococcinum® group, and 5 cases in Placebo group were reported. On the other hand, number of suspected COVID-19 cases was significantly less in all the three homeopathic medicine groups compared to placebo. The least number of suspected cases reported in the Oscillococcinum® group (aOR: 0.058; 95% confidence interval [CI]: 0.029, 0.114), followed by the Arsenicum album (aOR: 0.337; 95% CI: 0.238, 0.475) and Influenzinum (aOR: 0.539; 95% CI: 0.401, 0.726) groups.

Conclusion

Prespecified homeopathic medicines, particularly Oscillococcinum® and Arsenicum album 30C, may have a role in preventing COVID-19, especially in reducing the incidence of suspected or COVID-19-like respiratory illnesses. However, the result failed to demonstrate a statistically significant difference in the occurrence of confirmed cases of COVID-19 between the study groups. Further research is needed to evaluate the efficacy of these medicines in different populations and settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HomeopathyMateria MedicaCOVID-19 Drug TreatmentHumansDouble-Blind MethodMaleFemaleAdultMiddle AgedIndiaSARS-CoV-2

Stichwörter der Autor:innen

Arsenicum albumCOVID-19HomeopathyHomöopathieInfluenzinumOscillococcinum®PlaceboRandomisierte kontrollierte StudieRandomized controlled trial

Substanzen

Materia Medica

Autor:innen und Institutionen

  • International Cooperation Section, Ministry of Ayush (Government of India), New Delhi, India.
  • State Homoeopathic Dispensary, District Hospital, Darjeeling, India.
  • Department of Pathology and Microbiology, D. N. De Homoeopathic Medical College and Hospital, Kolkata, India.
  • Department of Community Medicine, Calcutta National Medical College and Hospital, Kolkata, India.
  • Department of Materia Medica, Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, Howrah, India.
  • Department of Pathology and Microbiology, Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, Howrah, India.

Zitieren

APA

Dutta, A., Manna, A., Ghosh, S., Mundle, M., Saha, M., Gourav, K., Maiti, S., & Chattopadhyay, B. (2024). Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial. Complementary Medicine Research. https://doi.org/10.1159/000536395

Vancouver

Dutta A, Manna A, Ghosh S, Mundle M, Saha M, Gourav K, et al. Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial. Complementary Medicine Research. 2024. doi:10.1159/000536395

BibTeX
@article{Dutta2024,
  author = {Dutta, Abhijit and Manna, Arijit and Ghosh, Shubhamoy and Mundle, Malay and Saha, Madhabananda and Gourav, Kumar and Maiti, Sukhdeb and Chattopadhyay, Bhargab},
  title = {Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial},
  journal = {Complementary Medicine Research},
  year = {2024},
  doi = {10.1159/000536395}
}
Kostenlos starten →